Ribociclib vs. Palbociclib in Patients With Advanced Breast Cancer Within the HER2-Enriched Intrinsic Subtype
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Aleix Prat, MD
Hospital Clínic of Barcelona / SOLTI
Principal Investigator - Dan G Stover, MD
Stefanie Spielman Comprehensive Breast Center
Principal Investigator - Lisa A Carey, MD
UNC Lineberger Comprehensive Cancer Center
Principal Investigator - Tomás Pascual, MD
Hospital Clínic of Barcelona / SOLTI cancer research group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
71 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Senhora Da Oliveira - Guimarães
Creixomil, Portugal
- Ipo Lisboa
Lisbon, Portugal
- Hospital Beatriz Ângelo
Loures, Portugal
- Instituto Portugues de Oncologia de Porto Francisco Gentil, Epe
Porto, Portugal
- Centro Hospitalar Vila Nova de Gaia
Vila Nova de Gaia, Portugal
- Hospital Son Llàtzer
Palma de Mallorca, Balearic Islands, Spain
- Institut Català D' Oncologia (ico Badalona)
Badalona, Barcelona, Spain
- Hospital del Mar
Barcelona, Barcelona, Spain
- Iob-Institute of Oncology. Hospital Quironsalud Barcelona
Barcelona, Barcelona, Spain
- Institut Català D'Oncologia (ico Hospitalet)
L'Hospitalet de Llobregat, Barcelona, Spain
- Hospital General de Catalunya
Sant Cugat del Vallès, Barcelona, Spain
- Hospital Universitario de Canarias
Santa Cruz de Tenerife, Canary Islands, Spain
- Institut Català D' Oncologia de Girona (ico Girona)
Girona, Girona, Spain
- Hospital Clínico Universitario de A Coruña
A Coruña, La Coruña, Spain
- Hospital Clínico Universitario de Santiago Chus
Santiago de Compostela, La Coruña, Spain
- Complejo Asistencial Universitario de León
León, León, Spain
- Hospital Universitario de Fuenlabrada
Fuenlabrada, Madrid, Spain
- Fundación Jiménez Díaz
Madrid, Madrid, Spain
- Hospital la Paz
Madrid, Madrid, Spain
- Hospital Universitario Ramón Y Cajal
Madrid, Madrid, Spain
- Hospital Universitario Virgen de la Arrixaca
El Palmar, Murcia, Spain
- Hospital Universitario Morales Meseguer
Murcia, Murcia, Spain
- Hospital Quiron Salud Sagrado Corazon Sevilla
Seville, Sevilla, Spain
- Hospital Universitario Virgen del Rocio
Seville, Sevilla, Spain
- Hospital Clínico Universitario Lozano Blesa
Zaragoza, Zaragoza, Spain
- Hospital General Universitario de Alicante
Alicante, Spain
- Hospital Clinic de Barcelona
Barcelona, Spain
- Vall D´hebron University Hospital
Barcelona, Spain
- Hospital de Basurto
Bilbao, Spain
- Complejo Hospitalario San Pedro de Alcántara
Cáceres, Spain
- H. Clínico San Cecilio de Granada
Granada, Spain
- Hospital Universitario Virgen de Las Nieves
Granada, Spain
- Hospital Universitario de Gran Canaria Doctor Negrin
Las Palmas, Spain
- Hospital Universitari Arnau de Vilanova de Lleida
Lleida, Spain
- Centro Integral Oncológico Clara Campal (ciocc)
Madrid, Spain
- Hospital Universitario 12 de Octubre
Madrid, Spain
- Hospital Universitario la Princesa
Madrid, Spain
- Hospital Universitario Puerta de Hierro de Majadahonda
Madrid, Spain
- Hospital Virgen de la Victoria
Málaga, Spain
- Hospital Sant Joan de Reus
Reus, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Mar 2022
- Primary completion
- 26 Mar 2026
- Completion
- 26 Mar 2026
- Last update posted
- 25 Jun 2026
- Registered enrollment
- 61
- Registry id
- NCT05207709
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.